A股盘前市场要闻速递（2025-08-01）

Group 1: Government Policies and Initiatives - The State Council approved the "Artificial Intelligence +" action plan to promote large-scale commercialization of AI applications across various sectors, emphasizing innovation-driven applications and a supportive ecosystem for AI development [1] - The National Development and Reform Commission (NDRC) aims to eliminate "involution" competition and standardize local investment attraction behaviors to promote healthy and high-quality development of the private economy [2] - The National Financial Regulatory Administration issued guidelines to regulate "benefit insurance," emphasizing the need for fair pricing and adherence to insurance principles [3] Group 2: Corporate News and Financial Performance - Sinopec expects a significant decline in net profit for the first half of 2025, projecting a decrease of 39.5% to 43.7% year-on-year, with estimated net profit ranging from RMB 201 billion to RMB 216 billion [5][6] - South Road Machinery announced that if its stock price continues to rise, it may apply for a trading suspension due to significant market volatility and potential irrational speculation [3] - Tibet Tourism reported a cumulative stock price increase of 135.98% from July 21 to July 31, indicating a risk of a sharp decline if trading anomalies persist [4] Group 3: Innovations and Developments - HaiSiKe received FDA acceptance for its new drug HSK3486, a key step towards international market entry for its innovative anesthetic [9] - Huahai Pharmaceutical's dual-target antibody drug HB0043 received clinical trial approval, representing a breakthrough in treating autoimmune diseases [11] - The company YingweiKe has developed a complete liquid cooling technology and solution, aiming to expand its market presence in data centers and computing equipment [7]